Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib. Joos L, Vetterli F, Jaeger T, Cozzio A, et al. Clin Exp Dermatol 2022;47:748-750.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Joos L, Vetterli F, Jaeger T, Cozzio A, et al. Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib. Clin Exp Dermatol 2022;47:748-750.
PMID: 34747511